EP0194599A3
(en)
|
1985-03-14 |
1988-01-20 |
Nissan Chemical Industries Ltd. |
Benzamide derivatives, process for producing the same, and soil fungicides containing the same
|
GB9122590D0
(en)
|
1991-10-24 |
1991-12-04 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
DE4410453A1
(de)
|
1994-03-25 |
1995-09-28 |
Hoechst Ag |
Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
|
GB9514160D0
(en)
|
1994-07-25 |
1995-09-13 |
Zeneca Ltd |
Aromatic compounds
|
JPH10512272A
(ja)
|
1995-01-19 |
1998-11-24 |
ノバルティス アクチエンゲゼルシャフト |
除草用組成物
|
EP0863708A1
(en)
|
1995-11-23 |
1998-09-16 |
Novartis AG |
Herbicidal composition
|
AU707574B2
(en)
|
1995-12-15 |
1999-07-15 |
Merck Frosst Canada & Co. |
Tri-aryl ethane derivatives as PDE IV inhibitors
|
JPH10114654A
(ja)
|
1996-10-09 |
1998-05-06 |
Fujisawa Pharmaceut Co Ltd |
新規用途
|
WO1998031226A1
(de)
|
1997-01-15 |
1998-07-23 |
Novartis Ag |
Herbizides mittel
|
GB9716657D0
(en)
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
DE19742951A1
(de)
|
1997-09-29 |
1999-04-15 |
Hoechst Schering Agrevo Gmbh |
Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
|
DE19802697A1
(de)
|
1998-01-24 |
1999-07-29 |
Bayer Ag |
Selektive Herbizide auf Basis von N-Aryl-triazolin(thi)onen und N-Arylsulfonylamino(thio)carbonyltriazolin(thi)onen
|
AU754616C
(en)
|
1998-02-13 |
2003-06-26 |
Kureha Corporation |
N-(phenylsulfonyl) picolinamide derivatives, process for producing the same, and herbicide
|
KR20010052235A
(ko)
|
1998-04-06 |
2001-06-25 |
후지야마 아키라 |
인돌 유도체
|
CZ20014366A3
(cs)
|
1999-06-10 |
2002-11-13 |
Warner-Lambert Company |
Způsob inhibice agregace amyloidních proteinů a zobrazení amyloidních usazenin za pouľití isoindolinových derivátů
|
DE19936438A1
(de)
|
1999-08-03 |
2001-02-08 |
Aventis Cropscience Gmbh |
Kombinationen von Herbiziden und Safenern
|
DE19940860A1
(de)
|
1999-08-27 |
2001-03-01 |
Bayer Ag |
Selektive Herbizide auf Basis eines substituierten Phenylsulfonyl aminocarbonyltriazolinons und Safenern II
|
DE19958381A1
(de)
|
1999-12-03 |
2001-06-07 |
Bayer Ag |
Herbizide auf Basis von N-Aryl-uracilen
|
WO2002015902A1
(en)
|
2000-08-23 |
2002-02-28 |
Merck & Co., Inc. |
Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
|
US6720338B2
(en)
|
2000-09-20 |
2004-04-13 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
UY26942A1
(es)
|
2000-09-20 |
2002-04-26 |
Abbott Lab |
N-acilsulfonamidas promotoras de la apoptosis
|
US20020055631A1
(en)
|
2000-09-20 |
2002-05-09 |
Augeri David J. |
N-acylsulfonamide apoptosis promoters
|
CA2427499A1
(en)
|
2000-10-10 |
2002-04-18 |
Smithkline Beecham Corporation |
Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
DE10119721A1
(de)
|
2001-04-21 |
2002-10-31 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylcyclohexandione und Safener
|
CN1529697B
(zh)
|
2001-05-31 |
2010-09-22 |
维科尔药物公司 |
用作血管紧张素ⅱ激动剂的三环化合物
|
UA75660C2
(en)
|
2001-06-28 |
2006-05-15 |
Pfizer Prod Inc |
Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
|
DE10145019A1
(de)
|
2001-09-13 |
2003-04-03 |
Bayer Cropscience Gmbh |
Kombinationen aus Herbiziden und Safenern
|
DE10146873A1
(de)
|
2001-09-24 |
2003-04-17 |
Bayer Cropscience Gmbh |
Heterocyclische Amide und -Iminderivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
|
AU2002360386A1
(en)
|
2001-11-14 |
2003-06-17 |
Teva Pharmaceutical Industries Ltd. |
Amorphous and crystalline forms of losartan potassium and process for their preparation
|
US20060100195A1
(en)
|
2001-11-19 |
2006-05-11 |
Takayuki Maruyama |
Remedies for urinary frequency
|
DE10157545A1
(de)
|
2001-11-23 |
2003-06-12 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylpyrazole und Safener
|
JP4471842B2
(ja)
|
2002-03-27 |
2010-06-02 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
アミド化合物および該化合物を用いる方法
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
DE60304862T2
(de)
|
2002-06-08 |
2006-11-23 |
Bayer Cropscience Gmbh |
Kombinationen von herbiziden aromatischen carbonsäuren und safener-mitteln
|
DE10237461A1
(de)
|
2002-08-16 |
2004-02-26 |
Bayer Cropscience Gmbh |
Herbizide Mittel enthaltend Benzoylpyrazole und Safener
|
AU2003288901A1
(en)
|
2002-09-06 |
2004-03-29 |
Merck And Co., Inc. |
Treatment of rheumatoid arthritis by inhibition of pde4
|
EP1562914A1
(en)
|
2002-10-22 |
2005-08-17 |
Merck Frosst Canada & Co. |
Nitric oxide releasing selective cyclooxygenase-2 inhibitors
|
GB0225548D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Compounds
|
WO2004046141A1
(en)
|
2002-11-21 |
2004-06-03 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
MXPA05006679A
(es)
|
2002-12-20 |
2005-08-16 |
Pfizer Prod Inc |
Inhibidores de la proteina de transferencia de trigliceridos microsomales.
|
BR0317323A
(pt)
|
2002-12-20 |
2005-11-16 |
Pfizer Prod Inc |
Inibidores de proteìna de transferência de triglicerìdeos microssomal
|
JP2006519258A
(ja)
|
2003-02-28 |
2006-08-24 |
エンサイシブ・ファーマシューティカルズ・インコーポレイテッド |
ピリジン、ピリミジン、キノリン、キナゾリンおよびナフタレン系のウロテンシン−ii受容体拮抗薬
|
AU2003219291A1
(en)
|
2003-03-24 |
2004-10-18 |
Vicore Pharma Ab |
Bicyclic compounds useful as angiotensin ii agonists
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
EP1682127B1
(en)
|
2003-11-14 |
2009-07-29 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
|
GB0328024D0
(en)
|
2003-12-03 |
2004-01-07 |
Glaxo Group Ltd |
Compounds
|
US20090131342A1
(en)
|
2004-01-22 |
2009-05-21 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
AU2005210474B2
(en)
|
2004-01-30 |
2011-07-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding cassette transporters
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
JP2007520543A
(ja)
|
2004-02-04 |
2007-07-26 |
ファイザー・プロダクツ・インク |
置換キノリン化合物
|
TW200533336A
(en)
|
2004-03-02 |
2005-10-16 |
Fujisawa Pharmaceutical Co |
Concomitant drugs
|
CN101768129B
(zh)
|
2004-03-05 |
2012-05-23 |
日产化学工业株式会社 |
异*唑啉取代苯甲酰胺化合物的制备中间体
|
WO2005099705A2
(en)
|
2004-03-24 |
2005-10-27 |
Bayer Pharmaceuticals Corporation |
Preparation of imidazole derivatives and methods of use
|
GB0410121D0
(en)
|
2004-05-06 |
2004-06-09 |
Glaxo Group Ltd |
Compounds
|
LT2502911T
(lt)
|
2004-06-24 |
2017-09-11 |
Vertex Pharmaceuticals Incorporated |
Atp surišančios kasetės transporterių moduliatoriai
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
JP4953297B2
(ja)
|
2004-09-15 |
2012-06-13 |
塩野義製薬株式会社 |
Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
|
MX2007003836A
(es)
|
2004-09-29 |
2007-08-20 |
Portola Pharm Inc |
2h-1,3-benzoxazin-4(3h)-onas sustituidas.
|
JP2008523139A
(ja)
|
2004-12-14 |
2008-07-03 |
アストラゼネカ・アクチエボラーグ |
置換アミノピリジン類及びその使用
|
DE602005013116D1
(de)
|
2004-12-23 |
2009-04-16 |
Glaxo Group Ltd |
Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
|
GB0428173D0
(en)
|
2004-12-23 |
2005-01-26 |
Astrazeneca Ab |
Compounds
|
AU2006251624A1
(en)
|
2005-05-24 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding cassette transporters
|
US20070032488A1
(en)
|
2005-08-05 |
2007-02-08 |
Genelabs Technologies, Inc. |
6-Membered aryl and heteroaryl derivatives for treating viruses
|
WO2007021982A2
(en)
|
2005-08-11 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
WO2007053641A2
(en)
|
2005-11-01 |
2007-05-10 |
Mars, Incorporated |
A-type procyanidins and inflammation
|
AU2006331565A1
(en)
|
2005-12-27 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in CFTR assays and methods therewith
|
PT3219705T
(pt)
|
2005-12-28 |
2020-05-20 |
Vertex Pharma |
Composições farmacêuticas da forma amorfa de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolina-3-carboxamida
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
NZ569327A
(en)
|
2005-12-28 |
2011-09-30 |
Vertex Pharma |
1-(benzo [d] [1,3] dioxol-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis
|
US7932283B2
(en)
|
2006-04-05 |
2011-04-26 |
Bayer Cropscience Ag |
Fungicide N-cyclopropyl-sulfonylamide derivatives
|
DK3091011T3
(en)
|
2006-04-07 |
2018-02-26 |
Vertex Pharma |
MODULATORS OF ATP BINDING CASSETTE TRANSPORT
|
US7553855B2
(en)
|
2006-05-12 |
2009-06-30 |
Vertex Pharmaceuticals Incorporated |
Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
CN101541783B
(zh)
|
2006-06-30 |
2014-10-01 |
苏尼西斯制药有限公司 |
吡啶酮基pdk1抑制剂
|
CA2668305C
(en)
|
2006-11-03 |
2017-01-03 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as cftr modulators
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
CN101687789A
(zh)
|
2007-02-12 |
2010-03-31 |
因特蒙公司 |
C型肝炎病毒复制的新颖抑制剂
|
WO2008141385A1
(en)
|
2007-05-21 |
2008-11-27 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
US8058299B2
(en)
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
EP2167471B1
(en)
|
2007-05-25 |
2013-10-16 |
Amgen Inc. |
Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
|
GB0716532D0
(en)
|
2007-08-24 |
2007-10-03 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
WO2009032116A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
NZ583848A
(en)
|
2007-09-14 |
2012-07-27 |
Vertex Pharma |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
US8765757B2
(en)
|
2007-11-16 |
2014-07-01 |
Merck Sharp & Dohme Corp. |
3-heterocyclic substituted indole derivatives and methods of use thereof
|
AU2013231151B2
(en)
|
2007-11-16 |
2015-06-25 |
Vertex Pharmaceuticals Incorporated |
Isoquinoline modulators of ATP-Binding Cassette transporters
|
GB0723794D0
(en)
|
2007-12-05 |
2008-01-16 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators and uses thereof
|
RS55298B1
(sr)
|
2007-12-07 |
2017-03-31 |
Vertex Pharma |
Proces za proizvodnju cikloalkilkarboksiamido-piridin benzoevih kiselina
|
LT2225230T
(lt)
|
2007-12-07 |
2017-01-25 |
Vertex Pharmaceuticals Incorporated |
3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il) benzoinės rūgšties kietos formos
|
AU2013270464B2
(en)
|
2008-03-31 |
2016-05-26 |
Vertex Pharmaceuticals Incorporated |
Pyridyl derivatives as CFTR modulators
|
US20110071197A1
(en)
|
2008-04-16 |
2011-03-24 |
Peter Nilsson |
Bis-aryl compounds for use as medicaments
|
US20110112193A1
(en)
|
2008-05-14 |
2011-05-12 |
Peter Nilsson |
Bis-aryl compounds for use as medicaments
|
EP2145537A1
(en)
|
2008-07-09 |
2010-01-20 |
Bayer CropScience AG |
Plant growth regulator
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
JP5575768B2
(ja)
|
2008-08-13 |
2014-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
薬学的組成物およびその投与
|
EP2326178A4
(en)
|
2008-08-21 |
2012-10-24 |
Glaxosmithkline Llc |
INHIBITORS OF PROLYL-HYDROXYLASE
|
AU2009288245B2
(en)
|
2008-08-27 |
2012-12-20 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
EP2349223A2
(en)
|
2008-09-29 |
2011-08-03 |
Vertex Pharmaceuticals Incorporated |
Dosage units of 3-(6-(1-(2,2-difluorobenzo [d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
ES2483690T3
(es)
|
2008-10-23 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística
|
NZ609962A
(en)
|
2008-11-06 |
2014-11-28 |
Vertex Pharma |
Modulators of atp-binding cassette transporters
|
UA104876C2
(uk)
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
EP2382197B1
(en)
|
2008-12-30 |
2016-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
JP5613176B2
(ja)
|
2009-01-19 |
2014-10-22 |
アッヴィ・インコーポレイテッド |
癌並びに免疫及び自己免疫疾患の治療用アポトーシス誘導剤
|
MX2011009188A
(es)
|
2009-03-11 |
2011-09-26 |
Bayer Cropscience Ag |
Cetoenoles sustituidos con haloalquilmetilenoxi-fenilo.
|
DK2408749T3
(en)
|
2009-03-20 |
2018-08-13 |
Vertex Pharma |
CYSTIC FIBROSE TRANSMEMBRAN CONDUCTOR CONTROLLER MODULATORS
|
EP2821400B1
(en)
|
2009-03-20 |
2017-09-27 |
Vertex Pharmaceuticals Incorporated |
Process for making modulators of cystic fibrosis transmembrane conductance regulator
|
EP2412708A4
(en)
|
2009-03-26 |
2014-07-23 |
Shionogi & Co |
SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE
|
WO2010123822A1
(en)
|
2009-04-20 |
2010-10-28 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
|
TWI561523B
(en)
|
2009-05-26 |
2016-12-11 |
Abbvie Bahamas Ltd |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
WO2011102514A1
(ja)
|
2010-02-22 |
2011-08-25 |
武田薬品工業株式会社 |
芳香環化合物
|
US8471029B2
(en)
|
2010-03-19 |
2013-06-25 |
Vertex Pharmaceutical Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
AU2011230508B2
(en)
|
2010-03-25 |
2016-04-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihyderoxypropyl)-6-fluoro-2- (1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide
|
HUE029611T2
(en)
|
2010-04-07 |
2017-03-28 |
Vertex Pharma |
3- (6- (1- (2,2-Difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid
|
AU2011237601B2
(en)
|
2010-04-07 |
2015-08-20 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
|
US8344137B2
(en)
|
2010-04-14 |
2013-01-01 |
Hoffman-La Roche Inc. |
3,3-dimethyl tetrahydroquinoline derivatives
|
AU2011242452A1
(en)
|
2010-04-22 |
2012-11-08 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
CN105130948A
(zh)
|
2010-04-22 |
2015-12-09 |
弗特克斯药品有限公司 |
制备环烷基甲酰胺基-吲哚化合物的方法
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
NZ606805A
(en)
|
2010-08-23 |
2015-03-27 |
Vertex Pharma |
Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
|
RU2013113627A
(ru)
|
2010-08-27 |
2014-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтическая композиция и ее введения
|
EP2630136A1
(en)
|
2010-10-21 |
2013-08-28 |
Universität des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
WO2012087938A1
(en)
|
2010-12-20 |
2012-06-28 |
Glaxosmithkline Llc |
Quinazolinone derivatives as antiviral agents
|
EP2471363A1
(de)
|
2010-12-30 |
2012-07-04 |
Bayer CropScience AG |
Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen
|
WO2012102297A1
(ja)
|
2011-01-26 |
2012-08-02 |
杏林製薬株式会社 |
ピラゾロピリジン誘導体、またはその薬理学的に許容される塩
|
JP2014508752A
(ja)
|
2011-02-17 |
2014-04-10 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
治療用の置換3−(ビフェニル−3−イル)−8,8−ジフルオロ−4−ヒドロキシ−1−アザスピロ[4.5]デカ−3−エン−2−オン
|
US9204640B2
(en)
|
2011-03-01 |
2015-12-08 |
Bayer Intellectual Property Gmbh |
2-acyloxy-pyrrolin-4-ones
|
AR085585A1
(es)
|
2011-04-15 |
2013-10-09 |
Bayer Cropscience Ag |
Vinil- y alquinilciclohexanoles sustituidos como principios activos contra estres abiotico de plantas
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
EP2714680B1
(en)
|
2011-05-27 |
2015-11-25 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
US9428464B2
(en)
|
2011-08-30 |
2016-08-30 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
AU2012307321B2
(en)
|
2011-09-16 |
2016-07-14 |
Bayer Intellectual Property Gmbh |
Use of acylsulfonamides for improving plant yield
|
BR112014006940A2
(pt)
|
2011-09-23 |
2017-04-04 |
Bayer Ip Gmbh |
uso de derivados de ácido 1-fenilpirazol-3-carboxílico 4-substituído como agentes contra estresse abiótico em plantas
|
IN2014KN00885A
(es)
|
2011-11-08 |
2015-10-02 |
Vertex Pharma |
|
US8426450B1
(en)
|
2011-11-29 |
2013-04-23 |
Helsinn Healthcare Sa |
Substituted 4-phenyl pyridines having anti-emetic effect
|
US20130186801A1
(en)
|
2012-01-25 |
2013-07-25 |
Vertex Pharmaceuticals Incorporated |
Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
3位置換プロリン誘導体
|
IL265430B2
(en)
|
2012-02-27 |
2024-08-01 |
Vertex Pharma |
Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
AU2012377446A1
(en)
|
2012-04-20 |
2014-10-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
WO2013177224A1
(en)
|
2012-05-22 |
2013-11-28 |
Genentech, Inc. |
N-substituted benzamides and their use in the treatment of pain
|
AU2013270681A1
(en)
|
2012-06-08 |
2014-12-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of CFTR -mediated disorders
|
WO2013185202A1
(en)
|
2012-06-14 |
2013-12-19 |
Beta Pharma Canada Inc |
Apoptosis inducers
|
KR101663436B1
(ko)
|
2012-07-06 |
2016-10-06 |
제넨테크, 인크. |
N-치환된 벤즈아미드 및 이의 사용 방법
|
AU2013290444B2
(en)
*
|
2012-07-16 |
2018-04-26 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
|
JP2015178458A
(ja)
|
2012-07-25 |
2015-10-08 |
杏林製薬株式会社 |
ベンゼン環縮合含窒素5員複素環式化合物、またはその薬理学的に許容される塩
|
CN103571906B
(zh)
|
2012-07-27 |
2018-12-11 |
上海泽元海洋生物技术有限公司 |
一种利用微藻高效生产虾青素的新方法
|
US8883784B2
(en)
|
2012-08-13 |
2014-11-11 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
WO2014028968A1
(en)
|
2012-08-21 |
2014-02-27 |
Peter Maccallum Cancer Institute |
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
JP6318156B2
(ja)
|
2012-09-06 |
2018-04-25 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼをモジュレートするための化合物および方法、ならびにその指標
|
US10093640B2
(en)
|
2012-09-21 |
2018-10-09 |
Vanderbilt University |
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
|
EP2914248B2
(en)
|
2012-11-02 |
2023-10-18 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of cftr mediated diseases
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
JP6277198B2
(ja)
|
2012-11-05 |
2018-02-07 |
ナント ホールディングス アイピー,エルエルシー |
置換インドール−5−オール誘導体及びそれらの治療適用
|
BR112015012926A2
(pt)
|
2012-12-05 |
2017-07-11 |
Bayer Cropscience Ag |
uso de 1-(aril etinil)-, 1-(heteroaril etinil)-, 1-(heterociclil etinil)- substituído e 1-(cicloalquenil etinil)-ciclohexanóis como agentes ativos contra o estresse abiótico da planta
|
BR112015013056A2
(pt)
|
2012-12-05 |
2017-07-11 |
Bayer Cropscience Ag |
uso de 1-(ariletinil)-, 1-(heteroariletinil)-, 1-(heterocicliletinil)- substituídos e 1-(cicloalqueniletinil)-bicicloalcanóis como agentes ativos contra o estresse abiótico da planta
|
UA115576C2
(uk)
|
2012-12-06 |
2017-11-27 |
Байєр Фарма Акцієнгезелльшафт |
Похідні бензимідазолу як антагоністи ер4
|
GB201223265D0
(en)
|
2012-12-21 |
2013-02-06 |
Selvita Sa |
Novel benzimidazole derivatives as kinase inhibitors
|
US20140199728A1
(en)
|
2013-01-14 |
2014-07-17 |
Amgen Inc. |
Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
|
EP2968303B1
(en)
|
2013-03-14 |
2018-07-04 |
The Trustees of Columbia University in the City of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
US10273243B2
(en)
|
2013-03-14 |
2019-04-30 |
The Trustees Of Columbia University In The City Of New York |
4-phenylpiperidines, their preparation and use
|
ES2966517T3
(es)
|
2013-03-15 |
2024-04-22 |
Cyclerion Therapeutics Inc |
Estimuladores de sGC
|
UA118965C2
(uk)
|
2013-03-29 |
2019-04-10 |
Такеда Фармасьютікал Компані Лімітед |
6-(5-гідрокси-1н-піразол-1-іл)нікотинамідні інгібітори рнd
|
WO2014180562A1
(en)
|
2013-05-07 |
2014-11-13 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
EP3000073B1
(en)
*
|
2013-05-21 |
2017-07-12 |
Sicpa Holding SA |
Identifying one- or two-dimensional bar codes via weighted image data combination
|
EP3004083A4
(en)
|
2013-05-24 |
2016-11-16 |
California Inst Biomedical Res |
COMPOUNDS FOR THE TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS
|
WO2015010832A1
(en)
|
2013-07-22 |
2015-01-29 |
Syngenta Participations Ag |
Microbiocidal heterocyclic derivatives
|
US10005728B2
(en)
|
2013-08-28 |
2018-06-26 |
Vanderbilt University |
Substituted indole Mcl-1 inhibitors
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
NZ720958A
(en)
|
2013-11-12 |
2022-02-25 |
Vertex Pharma |
Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
|
PT3925607T
(pt)
|
2014-04-15 |
2023-09-26 |
Vertex Pharma |
Composições farmacêuticas para o tratamento de doenças mediadas pelo regulador de condutância transmembranar da fibrose quística
|
AU2015328174B2
(en)
|
2014-10-06 |
2020-05-21 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|
CN107110831B
(zh)
|
2014-11-18 |
2020-02-21 |
弗特克斯药品有限公司 |
进行高通量试验高效液相色谱的方法
|
MA41253A
(fr)
|
2014-12-23 |
2017-10-31 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
CA2971855A1
(en)
|
2014-12-23 |
2016-06-30 |
Proteostasis Therapeutics, Inc. |
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
|
KR20170118166A
(ko)
|
2015-02-15 |
2017-10-24 |
에프. 호프만-라 로슈 아게 |
1-헤트(아릴)설폰일-(피롤리딘 또는 피페리딘)-2-카복스아마이드 유도체 및 trpa1 길항제로서의 이의 용도
|
CA2981495C
(en)
|
2015-03-31 |
2023-09-26 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated vx-661
|
UA124619C2
(uk)
|
2015-09-21 |
2021-10-20 |
Вертекс Фармасьютікалз (Юроп) Лімітед |
Введення дейтерованих підсилювачів cftr
|
WO2017172802A1
(en)
|
2016-03-30 |
2017-10-05 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
WO2017173274A1
(en)
|
2016-03-31 |
2017-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
JP7061076B2
(ja)
|
2016-04-07 |
2022-04-27 |
プロテオステイシス セラピューティクス,インコーポレイテッド |
アイバカフトール類似体を含有するケイ素原子
|
WO2017187321A1
(en)
|
2016-04-26 |
2017-11-02 |
AbbVie S.à.r.l. |
Modulators of cystic fibrosis transmembrane conductance regulator protein
|
US10138227B2
(en)
|
2016-06-03 |
2018-11-27 |
Abbvie S.Á.R.L. |
Heteroaryl substituted pyridines and methods of use
|
MA45397A
(fr)
|
2016-06-21 |
2019-04-24 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
DK3519401T3
(da)
|
2016-09-30 |
2021-11-22 |
Vertex Pharma |
Modulator af cystisk fibrosetransmembrankonduktansregulator, farmaceutiske sammensætninger, fremgangsmåder til behandling og fremgangsmåde til fremstilling af modulatoren
|
US10399940B2
(en)
|
2016-10-07 |
2019-09-03 |
Abbvie S.Á.R.L. |
Substituted pyrrolidines and methods of use
|
US9981910B2
(en)
|
2016-10-07 |
2018-05-29 |
Abbvie S.Á.R.L. |
Substituted pyrrolidines and methods of use
|
WO2018081377A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fibrosis
|
WO2018081381A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc |
Pyridazine derivatives, compositions and methods for modulating cftr
|
CA3041811A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating cftr
|
PE20200739A1
(es)
|
2016-11-18 |
2020-07-24 |
Cystic Fibrosis Found Therapeutics Inc |
Pirrolopirimidinas como potenciadores de cftr
|
AU2017371200B2
(en)
|
2016-12-09 |
2021-05-06 |
Vertex Pharmaceuticals Incorporated |
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
|
RU2753056C2
(ru)
|
2016-12-16 |
2021-08-11 |
Систик Файбросис Фаундейшн |
Бициклические гетероарильные производные в качестве стимуляторов cftr
|
US20200123137A1
(en)
|
2016-12-20 |
2020-04-23 |
AbbVie S.à.r.l. |
Deuterated cftr modulators and methods of use
|
CN110177788B
(zh)
|
2017-01-07 |
2023-03-24 |
重庆复创医药研究有限公司 |
作为bcl-2选择性凋亡诱导剂的化合物
|
TW201831471A
(zh)
|
2017-02-24 |
2018-09-01 |
盧森堡商艾伯維公司 |
囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法
|
WO2018183367A1
(en)
|
2017-03-28 |
2018-10-04 |
Van Goor Fredrick F |
Methods of treating cystic fibrosis in patients with residual function mutations
|
US20200055844A1
(en)
|
2017-04-28 |
2020-02-20 |
Proteostasis Therapeutics, Inc. |
4-sulfonylaminocarbonylquinoline derivatives for increasing cftr activity
|
US11253509B2
(en)
|
2017-06-08 |
2022-02-22 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|
US20210069174A1
(en)
|
2017-07-01 |
2021-03-11 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for treatment of cystic fibrosis
|
WO2019018395A1
(en)
|
2017-07-17 |
2019-01-24 |
Vertex Pharmaceuticals Incorporated |
METHODS OF TREATING CYSTIC FIBROSIS
|
WO2019018353A1
(en)
|
2017-07-17 |
2019-01-24 |
Vertex Pharmaceuticals Incorporated |
METHODS OF TREATING CYSTIC FIBROSIS
|
EP3662079A4
(en)
|
2017-07-31 |
2021-04-14 |
Technion Research & Development Foundation Limited |
METHODS OF DETECTION OF MODIFIED AND NON-MODIFIED DNA
|
MA49752A
(fr)
|
2017-08-02 |
2021-04-21 |
Vertex Pharma |
Procédés de préparation de composés de pyrrolidine
|
US10988454B2
(en)
|
2017-09-14 |
2021-04-27 |
Abbvie Overseas S.À.R.L. |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
|
US20210369749A1
(en)
|
2017-10-06 |
2021-12-02 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing cftr activity
|
WO2019079760A1
(en)
|
2017-10-19 |
2019-04-25 |
Vertex Pharmaceuticals Incorporated |
CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS
|
US20210228489A1
(en)
|
2017-12-04 |
2021-07-29 |
Vertex Pharmaceuticals Incorporated |
Compositions for treating cystic fibrosis
|
MA51039A
(fr)
|
2017-12-08 |
2020-10-14 |
Vertex Pharma |
Procédés pour préparer des modulateurs du régulateur de la conductance transmembranaire de la mucoviscidose
|
TWI810243B
(zh)
|
2018-02-05 |
2023-08-01 |
美商維泰克斯製藥公司 |
用於治療囊腫纖化症之醫藥組合物
|
US20210009560A1
(en)
|
2018-03-30 |
2021-01-14 |
Vertex Pharmaceuticals Incorporated |
Crystalline forms of modulators of cftr
|
WO2019195739A1
(en)
|
2018-04-05 |
2019-10-10 |
Alexander Russell Abela |
Modulators of cystic fibrosis transmembrane conductance regulator
|
US11414439B2
(en)
|
2018-04-13 |
2022-08-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
|
WO2020214921A1
(en)
|
2019-04-17 |
2020-10-22 |
Vertex Pharmaceuticals Incorporated |
Solid forms of modulators of cftr
|
WO2020242935A1
(en)
|
2019-05-29 |
2020-12-03 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|